Subtopic Deep Dive
Molecular Pathogenesis of Idiopathic Hypereosinophilia
Research Guide
What is Molecular Pathogenesis of Idiopathic Hypereosinophilia?
Molecular pathogenesis of idiopathic hypereosinophilia studies cytokine dysregulation, eosinophil activation pathways, and genetic drivers in fusion-negative hypereosinophilic syndrome cases.
Research focuses on idiopathic hypereosinophilic syndrome (HES) excluding known fusions like FIP1L1-PDGFRA, emphasizing IL-5 signaling and chemokine roles (Weller and Bubley, 1994; 937 citations). Key papers identify eotaxin for eosinophil recruitment (Ponath et al., 1996; 708 citations) and PDGF signaling in related disorders (Andræ et al., 2008; 2373 citations). Over 10 high-citation papers from provided lists address eosinophil biology and classification (Valent et al., 2012; 744 citations).
Why It Matters
Understanding molecular drivers in idiopathic HES enables therapies targeting IL-5 pathways beyond fusion inhibitors, as Sanderson (1992) links IL-5 to eosinophil production (783 citations). Weller and Bubley (1994) define HES organ damage risks, guiding diagnostic criteria refined by Valent et al. (2012) for personalized treatment. PDGF pathway insights from Andræ et al. (2008) inform kinase inhibitors in hypereosinophilia mimics, while eotaxin roles (Ponath et al., 1996) support chemokine blockers in trials.
Key Research Challenges
Identifying fusion-negative drivers
Distinguishing idiopathic HES from myeloid neoplasms lacks specific genetic markers beyond PDGFRA fusions (Tefferi and Vardiman, 2007; 992 citations). MPL mutations like W515L occur in related myeloproliferative disorders but rarely in pure eosinophilia (Pikman et al., 2006; 1389 citations). Comprehensive omics needed for novel variants.
Dysregulated cytokine profiling
IL-5 dominates eosinophil activation, but variable expression complicates pathogenesis models (Sanderson, 1992; 783 citations). Eotaxin-3 profiles differ across eosinophilic disorders (Blanchard, 2006; 845 citations). Quantifying pathway contributions remains inconsistent.
Heterogeneous disease classification
Idiopathic HES criteria evolved but exclude syndromes with unclear molecular bases (Weller and Bubley, 1994; 937 citations). Consensus proposals struggle with variant forms (Valent et al., 2012; 744 citations). Standardizing subtypes hinders targeted therapies.
Essential Papers
Role of platelet-derived growth factors in physiology and medicine
Johanna Andræ, R Gallini, Christer Betsholtz · 2008 · Genes & Development · 2.4K citations
Platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) have served as prototypes for growth factor and receptor tyrosine kinase function for more than 25 years. Studies of PDGFs and P...
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Yana Pikman, Benjamin H. Lee, Thomas Mercher et al. · 2006 · PLoS Medicine · 1.4K citations
Activation of JAK-STAT signaling via MPLW515L is an important pathogenetic event in patients with JAK2V617F-negative MF. The bone marrow transplant model of MPLW515L-mediated myeloproliferative dis...
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
Ayalew Tefferi, J. W. Vardiman · 2007 · Leukemia · 992 citations
Eosinophils: changing perspectives in health and disease
Helene F. Rosenberg, Kimberly D. Dyer, Paul S. Foster · 2012 · Nature reviews. Immunology · 942 citations
The idiopathic hypereosinophilic syndrome
PF Weller, Glenn J. Bubley · 1994 · Blood · 937 citations
Abstract THE IDIOPATHIC hypereosinophilic syndrome (HES) is a leukoproliferative disorder, or more likely disorders, marked by a sustained overproduction of eosinophils. The distinctiveness of the...
Eosinophilic gastrointestinal disorders (EGID)
Marc E. Rothenberg · 2004 · Journal of Allergy and Clinical Immunology · 908 citations
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis
Carine Blanchard · 2006 · Journal of Clinical Investigation · 845 citations
Eosinophilic esophagitis (EE) is an emerging disorder with a poorly understood pathogenesis. In order to define disease mechanisms, we took an empirical approach analyzing esophageal tissue by a ge...
Reading Guide
Foundational Papers
Start with Weller and Bubley (1994; 937 citations) for HES definition, Sanderson (1992; 783 citations) for IL-5 centrality, and Andræ et al. (2008; 2373 citations) for PDGF context in related disorders.
Recent Advances
Study Rosenberg et al. (2012; 942 citations) for eosinophil perspectives and Valent et al. (2012; 744 citations) for updated eosinophilic disorder criteria.
Core Methods
Core techniques include eotaxin cloning/chemotaxis assays (Ponath et al., 1996), mutation screening (Pikman et al., 2006), WHO classification algorithms (Tefferi and Vardiman, 2007), and gene-expression profiling (Blanchard, 2006).
How PapersFlow Helps You Research Molecular Pathogenesis of Idiopathic Hypereosinophilia
Discover & Search
Research Agent uses searchPapers('idiopathic hypereosinophilia molecular pathogenesis -FIP1L1-PDGFRA') to find Weller and Bubley (1994), then citationGraph reveals 900+ downstream papers on HES, and findSimilarPapers expands to IL-5 dysregulation studies like Sanderson (1992). exaSearch queries 'fusion-negative HES cytokine omics' for recent omics profiles citing Rosenberg et al. (2012).
Analyze & Verify
Analysis Agent applies readPaperContent on Pikman et al. (2006) to extract MPLW515L prevalence in eosinophilia, verifies rarity via verifyResponse (CoVe) against Tefferi and Vardiman (2007), and runPythonAnalysis parses cytokine expression data from Blanchard (2006) with pandas for statistical pathway correlations. GRADE grading scores IL-5 evidence as high from Sanderson (1992).
Synthesize & Write
Synthesis Agent detects gaps in fusion-negative drivers post-citationGraph of Andræ et al. (2008), flags contradictions between HES classifications (Weller 1994 vs. Valent 2012), and exportMermaid diagrams PDGF/IL-5 pathways. Writing Agent uses latexEditText for HES review sections, latexSyncCitations integrates 10 provided papers, and latexCompile generates polished manuscripts.
Use Cases
"Analyze cytokine gene expression datasets from idiopathic HES patients vs. controls"
Research Agent → searchPapers('HES omics IL-5 eotaxin') → Analysis Agent → readPaperContent(Blanchard 2006) → runPythonAnalysis(pandas differential expression, matplotlib heatmaps) → outputs CSV of dysregulated genes with stats.
"Draft LaTeX review on molecular drivers in fusion-negative hypereosinophilia"
Synthesis Agent → gap detection on citationGraph(Weller 1994) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Valent 2012, Ponath 1996) → latexCompile → outputs compiled PDF with figures.
"Find code for eosinophil signaling pathway simulations from HES papers"
Research Agent → searchPapers('eosinophil JAK-STAT simulation code') → paperExtractUrls(Pikman 2006) → paperFindGithubRepo → githubRepoInspect → outputs runnable Python models of MPL signaling.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'idiopathic HES pathogenesis', chains citationGraph → findSimilarPapers → structured report with GRADE-scored evidence from Weller (1994). DeepScan applies 7-step analysis: readPaperContent(Andræ 2008) → verifyResponse(CoVe) → runPythonAnalysis on PDGF data → checkpoint critiques. Theorizer generates hypotheses on novel cytokine drivers from IL-5/eotaxin synthesis (Sanderson 1992, Ponath 1996).
Frequently Asked Questions
What defines idiopathic hypereosinophilia molecularly?
Idiopathic HES involves sustained eosinophilia without known fusions, marked by cytokine overproduction like IL-5 (Weller and Bubley, 1994; 937 citations).
What methods study its pathogenesis?
Omics profiling, chemokine assays (eotaxin; Ponath et al., 1996), and signaling analyses (PDGF; Andræ et al., 2008) identify drivers.
What are key papers?
Foundational: Weller and Bubley (1994; 937 citations) on HES syndrome; Sanderson (1992; 783 citations) on IL-5; recent: Valent et al. (2012; 744 citations) on classification.
What open problems exist?
Fusion-negative genetic drivers and heterogeneous cytokine roles remain unresolved, lacking specific markers beyond IL-5/eotaxin (Pikman et al., 2006).
Research Eosinophilic Disorders and Syndromes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Molecular Pathogenesis of Idiopathic Hypereosinophilia with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers